Innate immune cells at injection site and draining lymph node

Innate immune cells at the injection site and draining lymph node refers to the coordinated cellular response initiated by the administration of vaccines, adjuvants, or therapeutic agents. This process involves the rapid recruitment of innate immune cells—such as neutrophils, monocytes, macrophages, and dendritic cells—to the site of injection in response to tissue damage or specific molecular patterns (Awate et al., 2013). These cells internalize antigens and become activated by adjuvants, which provide necessary co-stimulatory signals (Liang et al., 2013). Subsequently, these activated antigen-presenting cells migrate via lymphatic vessels to the draining lymph nodes, where they interact with the adaptive immune system to initiate T-cell and B-cell responses (Itano & Jenkins, 2003). While this environment is the primary site of action for many immunotherapies and vaccines, it represents a complex physiological process and a collection of cell types rather than a single molecular target (Kohl et al., 2003).

Other names

Local innate immune responseInjection site immune environmentVaccine-induced innate response

Recruitment of innate immune cells to the injection site, activation via pattern recognition receptors, and migration to draining lymph nodes for antigen presentation.